The Team
The team is an optimal combination of deep medical science experience with solid business development and management knowledge, as well as an extensive experience in legal, regulatory and IP-aspects. We also have knowledge in quality management, CMC and product development as well as a deep knowledge in preparation and management of clinical studies. Members of the board and the advisory board represent experienced investors and financial experts and strategic expertise. Thus, the company is well prepared both for conducting a clinical development and for the commercialization of the TCP-25 gel.
The Board
Lena Mårtensson
Chairman
Lena Mårtensson has extensive experience from the medical device and pharmaceutical industry at Gambro, Pfizer, AstraZeneca and LEO A/S and others. For the past 20 years she has worked mainly in business development focusing on licensing negotiations of major drug projects and purchasing of businesses.
Artur Schmidtchen
Board member
Artur Schmidtchen is the co-founder of Xinnate. He is a professor, MD, Head of Dermatology at Lund University, a senior consultant at Skåne University hospital (an established wound care treatment center). He is also an affiliated professor at Copenhagen University. Artur has a deep understanding of the science and the clinical need and has a large network, both in the scientific and clinical communities.
Kristian Ford
Legal Advisor
Kristian Ford has extensive experience of M&A, private equity and general corporate matters from working with several domestic and global clients across a wide range of industries. Kristian assists businesses and their owners with legal advice within M&A, general business and contract law as well as corporate law. Kristian also sits on several company boards, gives speeches at conferences around the world and teaches at the University of Lund in Sweden.